A consistent failure to achieve profitability has led most investors to ditch the stock of Canadian pot producer Aurora Cannabis (NYSE:ACB) in 2020. Year to date, the stock is down over 68%. The benchmark Horizons Marijuana Life Sciences ETF is down just 15% in that time.
The company’s second-quarter 2021 earnings release arguably contained several negative developments that disappointed investors. But I think Aurora’s future a year from now could be brighter than today’s financials may suggest. Let’s look at why taking a small stake in Aurora now could pay off in the medium term.
Another lackluster quarter
During the first quarter of 2021, Aurora’s net revenue decreased to $67.8 million Canadian dollars from CA$75.2 million in Q1 2020. The company managed to sell…
Original Author Link click here to read complete story..